These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21949409)

  • 1. Drug solubilization effect of lauroyl-L-glutamate.
    Ariki R; Hirano A; Arakawa T; Shiraki K
    J Biochem; 2012 Jan; 151(1):27-33. PubMed ID: 21949409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine increases the solubility of alkyl gallates through interaction with the aromatic ring.
    Ariki R; Hirano A; Arakawa T; Shiraki K
    J Biochem; 2011 Apr; 149(4):389-94. PubMed ID: 21278386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine-assisted solubilization system for drug substances: solubility experiment and simulation.
    Hirano A; Kameda T; Arakawa T; Shiraki K
    J Phys Chem B; 2010 Oct; 114(42):13455-62. PubMed ID: 20925397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubility enhancement of gluten and organic compounds by arginine.
    Arakawa T; Kita Y; Koyama AH
    Int J Pharm; 2008 May; 355(1-2):220-3. PubMed ID: 18242019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-solubilization of poorly soluble drugs by micellization and complexation.
    Rao VM; Nerurkar M; Pinnamaneni S; Rinaldi F; Raghavan K
    Int J Pharm; 2006 Aug; 319(1-2):98-106. PubMed ID: 16765542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refolding single-chain antibody (scFv) using lauroyl-L-glutamate as a solubilization detergent and arginine as a refolding additive.
    Kudou M; Ejima D; Sato H; Yumioka R; Arakawa T; Tsumoto K
    Protein Expr Purif; 2011 May; 77(1):68-74. PubMed ID: 21195184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
    Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
    Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrins as pharmaceutical solubilizers.
    Brewster ME; Loftsson T
    Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel protein refolding system using lauroyl-l-glutamate as a solubilizing detergent and arginine as a folding assisting agent.
    Kudou M; Yumioka R; Ejima D; Arakawa T; Tsumoto K
    Protein Expr Purif; 2011 Jan; 75(1):46-54. PubMed ID: 20817098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine oxidase inhibitory activity of alkyl gallates.
    Masuoka N; Nihei K; Kubo I
    Mol Nutr Food Res; 2006 Aug; 50(8):725-31. PubMed ID: 16865746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
    Leal PC; Mascarello A; Derita M; Zuljan F; Nunes RJ; Zacchino S; Yunes RA
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1793-6. PubMed ID: 19232493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
    Yasuji T; Takeuchi H; Kawashima Y
    Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trapping of glyoxal by propyl, octyl and dodecyl gallates and their mono-glyoxal adducts.
    Hou Y; Xie Z; Cui H; Lu Y; Zheng T; Sang S; Lv L
    Food Chem; 2018 Dec; 269():396-403. PubMed ID: 30100451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alkyl gallates on P-glycoprotein function.
    Kitagawa S; Nabekura T; Kamiyama S; Takahashi T; Nakamura Y; Kashiwada Y; Ikeshiro Y
    Biochem Pharmacol; 2005 Oct; 70(8):1262-6. PubMed ID: 16139251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
    Shegokar R; Müller RH
    Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Salmonella activity of alkyl gallates.
    Kubo I; Fujita K; Nihei K
    J Agric Food Chem; 2002 Nov; 50(23):6692-6. PubMed ID: 12405763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stacking complexation by nicotinamide: a useful way of enhancing drug solubility.
    Sanghvi R; Evans D; Yalkowsky SH
    Int J Pharm; 2007 May; 336(1):35-41. PubMed ID: 17145146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles.
    Tammela P; Laitinen L; Galkin A; Wennberg T; Heczko R; Vuorela H; Slotte JP; Vuorela P
    Arch Biochem Biophys; 2004 May; 425(2):193-9. PubMed ID: 15111127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.